Open AccessLong-term therapy of Kaposi’s sarcoma with the use of prospidium chloride and mTOR receptor inhibitors in а patient after kidney transplantation
Author(s) -
Е. В. Парабина,
Б. И. Яремин,
М. М. Каабак
Publication year - 2020
Publication title -
transplantologiâ
Language(s) - English
Resource type - Journals
eISSN - 2542-0909
pISSN - 2074-0506
DOI - 10.23873/2074-0506-2020-12-3-213-219
Subject(s) - medicine , sarcoma , discovery and development of mtor inhibitors , kidney transplantation , transplantation , pi3k/akt/mtor pathway , chemotherapy , oncology , pathology , biology , apoptosis , biochemistry
A case of a long-term management of a patient with Kaposi’s sarcoma developed as presumably related to a “standard”immunosuppressive therapy after kidney transplantation has been described. Immunosuppressive therapy conversionto mTOR receptor inhibitors and administering chemotherapy with prospidium chloride allowed for a long-termremission of the disease and a satisfactory clinical outcome.